BACKGROUND: Little is known about the genetic alterations in multiple primary cancers of the gastrointestinal tract. Microsatellite instability (MSI) is frequently observed in hereditary non-polyposis colorectal cancer (HNPCC), and multiple primary cancers is a feature of this syndrome. AIMS: To identify MSI incidence, target gene mutation, and mismatch repair (MMR) protein status in patients with multiple primary cancers of the gastrointestinal tract. SUBJECTS: Fifty seven cancers from 22 Japanese patients with multiple primary cancers of the stomach, duodenum, colon, and rectum. METHODS: MSI was examined at 5-7 microsatellite loci. Mutation analysis for TGFbetaRII, IGFIIR, and BAX was performed in cancers with MSI. MMR protein status was examined by immunohistochemical analysis using a monoclonal antibody against hMSH2 and hMLH1. RESULTS: MSI was observed in 16 of 22 patients (73%) and in 29 of 57 lesions (51%). High frequency MSI (MSI-H) was found often in patients with multiple cancers in the same organ (p = 0.042), especially in multiple gastric cancer patients (p = 0.038). In contrast, patients with multiple cancers in different organs had a tendency to show low frequency MSI (MSI-L) or microsatellite stable (MSS) phenotype. Both target gene mutation and decreased expression of MMR protein were found only in seven lesions of three patients with MSI at more than four microsatellite loci. CONCLUSIONS: These results suggest that genetic instability may play an important role in the development of multiple gastrointestinal cancers but there may be different genetic alterations between multiple gastrointestinal cancers of the same and different organs.
BACKGROUND: Little is known about the genetic alterations in multiple primary cancers of the gastrointestinal tract. Microsatellite instability (MSI) is frequently observed in hereditary non-polyposis colorectal cancer (HNPCC), and multiple primary cancers is a feature of this syndrome. AIMS: To identify MSI incidence, target gene mutation, and mismatch repair (MMR) protein status in patients with multiple primary cancers of the gastrointestinal tract. SUBJECTS: Fifty seven cancers from 22 Japanese patients with multiple primary cancers of the stomach, duodenum, colon, and rectum. METHODS:MSI was examined at 5-7 microsatellite loci. Mutation analysis for TGFbetaRII, IGFIIR, and BAX was performed in cancers with MSI. MMR protein status was examined by immunohistochemical analysis using a monoclonal antibody against hMSH2 and hMLH1. RESULTS:MSI was observed in 16 of 22 patients (73%) and in 29 of 57 lesions (51%). High frequency MSI (MSI-H) was found often in patients with multiple cancers in the same organ (p = 0.042), especially in multiple gastric cancerpatients (p = 0.038). In contrast, patients with multiple cancers in different organs had a tendency to show low frequency MSI (MSI-L) or microsatellite stable (MSS) phenotype. Both target gene mutation and decreased expression of MMR protein were found only in seven lesions of three patients with MSI at more than four microsatellite loci. CONCLUSIONS: These results suggest that genetic instability may play an important role in the development of multiple gastrointestinal cancers but there may be different genetic alterations between multiple gastrointestinal cancers of the same and different organs.
Authors: R F Souza; R Appel; J Yin; S Wang; K N Smolinski; J M Abraham; T T Zou; Y Q Shi; J Lei; J Cottrell; K Cymes; K Biden; L Simms; B Leggett; P M Lynch; M Frazier; S M Powell; N Harpaz; H Sugimura; J Young; S J Meltzer Journal: Nat Genet Date: 1996-11 Impact factor: 38.330
Authors: C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava Journal: Cancer Res Date: 1998-11-15 Impact factor: 12.701
Authors: S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein Journal: Science Date: 1995-06-02 Impact factor: 47.728
Authors: B Liu; R Parsons; N Papadopoulos; N C Nicolaides; H T Lynch; P Watson; J R Jass; M Dunlop; A Wyllie; P Peltomäki; A de la Chapelle; S R Hamilton; B Vogelstein; K W Kinzler Journal: Nat Med Date: 1996-02 Impact factor: 53.440
Authors: A Horii; H J Han; M Shimada; A Yanagisawa; Y Kato; H Ohta; W Yasui; E Tahara; Y Nakamura Journal: Cancer Res Date: 1994-07-01 Impact factor: 12.701
Authors: L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola Journal: Cancer Res Date: 1994-04-01 Impact factor: 12.701
Authors: J M Chong; M Fukayama; Y Hayashi; T Takizawa; M Koike; M Konishi; R Kikuchi-Yanoshita; M Miyaki Journal: Cancer Res Date: 1994-09-01 Impact factor: 12.701
Authors: Ulysses Ribeiro; Uana M Jorge; Adriana V Safatle-Ribeiro; Osmar K Yagi; Cristovam Scapulatempo; Rodrigo O Perez; Carlos E P Corbett; Venâncio A F Alves; Bruno Zilberstein; Joaquim Gama-Rodrigues Journal: J Gastrointest Surg Date: 2007-03 Impact factor: 3.267